Eiji Shinozaki

18PUBLICATIONS
108CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 27, 2026
High-dose dexamethasone and prolonged infusion time prevent oxaliplatin-related hypersensitivity reactions in patients with metastatic colorectal cancer.

|May 04, 2026
A New Era of Salvage-Line Treatment for Metastatic Colorectal Cancer: The Role and Clinical Significance of Circulating Tumor DNA.

|Nov 04, 2025
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer.

Yusuke Kinugasa, Kay Uehara, Kensei Yamaguchi

|Aug 07, 2025
ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial.

Takashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda

|Jul 21, 2025
Effect of pretreatment vascular endothelial growth factor inhibitor use on the safety and efficacy of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.

Koshiro Fukuda, Hiroki Osumi, Akira Ooki

|Feb 27, 2025
Impact of early tumor shrinkage and depth of response in patients with BRAF V600E-mutant metastatic colorectal cancer.

Shohei Udagawa, Hiroki Osumi, Akira Ooki

Pageof 3

Frequent Collaborators

9 joint publications

Hiroki Osumi

8 joint publications

Kensei Yamaguchi

5 joint publications

Takeru Wakatsuki

5 joint publications

Mariko Ogura